Business Description
Sprint Bioscience AB
ISIN : SE0006343745
Compare
Compare
Traded in other countries / regions
SPRINT.Sweden5JA1.Germany IPO Date
2020-08-06Description
Sprint Bioscience AB is a Sweden based company involved in developing drugs focused on cancer and metabolism. The project portfolio of the company includes STK25, VPS34, and PIP4K2.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.47 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | -2.66 | |||||
| Beneish M-Score | 2391.39 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -7.2 | |||||
| 3-Year EBITDA Growth Rate | 75.6 | |||||
| 3-Year EPS without NRI Growth Rate | 83.7 | |||||
| 3-Year Book Growth Rate | 4.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 54.09 | |||||
| 9-Day RSI | 50.85 | |||||
| 14-Day RSI | 51.08 | |||||
| 6-1 Month Momentum % | -44.79 | |||||
| 12-1 Month Momentum % | 124.88 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.71 | |||||
| Quick Ratio | 1.71 | |||||
| Cash Ratio | 1.44 | |||||
| Days Sales Outstanding | 2.16 | |||||
| Days Payable | 115.35 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -38.7 | |||||
| Shareholder Yield % | -0.03 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 80.06 | |||||
| Operating Margin % | 8.84 | |||||
| Net Margin % | 12.83 | |||||
| FCF Margin % | 20.49 | |||||
| ROE % | 41.61 | |||||
| ROA % | 18.61 | |||||
| ROIC % | 24.19 | |||||
| ROC (Joel Greenblatt) % | 214.32 | |||||
| ROCE % | 31.7 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 10.58 | |||||
| PE Ratio without NRI | 10.58 | |||||
| Price-to-Owner-Earnings | 6.14 | |||||
| PS Ratio | 1.3 | |||||
| PB Ratio | 3.58 | |||||
| Price-to-Tangible-Book | 3.03 | |||||
| Price-to-Free-Cash-Flow | 5.88 | |||||
| Price-to-Operating-Cash-Flow | 5.59 | |||||
| EV-to-EBIT | 7.24 | |||||
| EV-to-EBITDA | 6.69 | |||||
| EV-to-Revenue | 0.7 | |||||
| EV-to-FCF | 3.1 | |||||
| Price-to-Graham-Number | 1.3 | |||||
| Price-to-Net-Current-Asset-Value | 4.54 | |||||
| Price-to-Net-Cash | 9.08 | |||||
| Earnings Yield (Greenblatt) % | 13.81 | |||||
| FCF Yield % | 17.06 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sprint Bioscience AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 5.9 | ||
| EPS (TTM) (€) | 0.009 | ||
| Beta | -0.48 | ||
| Volatility % | 285.16 | ||
| 14-Day RSI | 51.08 | ||
| 14-Day ATR (€) | 0.006875 | ||
| 20-Day SMA (€) | 0.094045 | ||
| 12-1 Month Momentum % | 124.88 | ||
| 52-Week Range (€) | 0.0202 - 0.231 | ||
| Shares Outstanding (Mil) | 69.82 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sprint Bioscience AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sprint Bioscience AB Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sprint Bioscience AB Frequently Asked Questions
What is Sprint Bioscience AB(FRA:5JA1)'s stock price today?
The current price of FRA:5JA1 is €0.09. The 52 week high of FRA:5JA1 is €0.23 and 52 week low is €0.02.
When is next earnings date of Sprint Bioscience AB(FRA:5JA1)?
The next earnings date of Sprint Bioscience AB(FRA:5JA1) is 2024-08-28.
Does Sprint Bioscience AB(FRA:5JA1) pay dividends? If so, how much?
Sprint Bioscience AB(FRA:5JA1) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers